A definitive guide for pharmaceutical sponsors and CRO clinical operations leaders on building sponsor recruitment support infrastructure through community clinic partnerships, embedded research models, and diverse patient enrollment strategies.
Sponsor recruitment support is one of the most consequential investments a clinical operations team can make. Yet for many sponsors, recruitment planning remains an afterthought: a list of sites selected from a database, a generic advertising budget, and an optimistic enrollment timeline that unravels within the first quarter. The result is familiar. Timelines extend. Per patient costs climb. Diverse enrollment targets are missed. And the trial’s scientific credibility suffers for it.
This guide takes a different approach. It lays out a structured framework for how sponsors can build sponsor recruitment support that is proactive, community embedded, and operationally integrated from the moment a protocol is finalized. The focus is on community clinics: why they represent the highest leverage enrollment channel available to sponsors today, and what it takes to activate them effectively.
Whether you are planning a Phase II proof of concept study, a Phase III pivotal trial with diversity enrollment requirements, or an ongoing post market study that requires sustained patient volume, the principles here apply. Sponsor recruitment support that is built on community infrastructure does not just solve a short term enrollment problem. It builds a durable clinical research capability.
Who This Guide Is For
Pharmaceutical sponsors, biotech clinical operations leaders, and CRO project managers evaluating sponsor recruitment support partners for community clinic trials, diverse enrollment programs, and embedded site models across the United States.
Why Sponsor Recruitment Support Fails at the Site Selection Stage
Most sponsor recruitment support failures are not recruitment failures. They are site selection failures that manifest later as recruitment problems. When a sponsor places a trial exclusively at academic medical centers, they are not choosing their best enrollment option. They are choosing their most familiar one.
Academic centers bring name recognition, established regulatory infrastructure, and experienced investigators. They also bring competing research priorities, subspecialty patient panels that skew toward referral populations, and institutional timelines that extend site activation by months. The patients they see are disproportionately white, privately insured, and located within a short distance of a major metropolitan research hospital.
The patients who are most affected by the diseases sponsors are studying, and whose inclusion would make the resulting data most scientifically meaningful, are often not walking through those doors. They are being treated at community health centers, independent primary care practices, and federally qualified health centers that have never been approached about clinical trial participation.
Effective sponsor recruitment support begins by widening the aperture of site selection to include these community settings. Not as a diversity checkbox, but as a core enrollment strategy that produces faster timelines, lower screen failure rates, and trial data that accurately reflects the population the therapy will ultimately serve.
Key Insight
More than 70% of Americans live within five miles of a community clinic or independent primary care practice. Fewer than 5% of clinical trials are placed at those settings. That gap is the enrollment opportunity that sponsor recruitment support through community infrastructure is designed to close.
The Community Clinic Advantage in Sponsor Recruitment Support
Community clinics offer three structural advantages for sponsor recruitment support that academic centers cannot replicate: patient volume in underrepresented demographics, established trust relationships that accelerate consent, and flexibility in operations that makes protocol integration faster.
Patient Volume in Target Demographics
Community clinics disproportionately serve the patient populations most relevant to Phase II and Phase III trial design: racially and ethnically diverse adults, patients managing multiple chronic conditions, older adults without subspecialty care relationships, and patients in suburban and rural geographies that academic centers do not reach. These are also the populations where FDA diversity guidance and FDORA Act requirements are most focused. Sponsor recruitment support that taps community clinic networks does not just solve an enrollment volume problem. It solves a representativeness problem that affects the regulatory strength of the entire submission.
Trust Relationships That Reduce Hesitancy
Clinical trial participation hesitancy is not primarily a knowledge problem. It is a trust problem. Patients who have been treated by the same community physician for years, within the same neighborhood where they live, respond differently to a trial invitation than a patient referred to an unfamiliar academic research center. Sponsor recruitment support that works through community providers leverages existing trust relationships rather than trying to build them from scratch through advertising campaigns. The conversion from eligible patient to consented participant is structurally higher in community settings for this reason.
Operational Flexibility for Protocol Integration
Community clinics operate with leaner administrative structures than academic medical centers. When provided with the right research infrastructure, including embedded coordinators, regulatory support, and data management tools, they can activate faster, adapt to protocol amendments more quickly, and sustain enrollment over longer study periods without the institutional friction that slows academic sites. Sponsor recruitment support built on community infrastructure is not a lower quality alternative to academic site placement. It is a higher performance model that requires the right operational partner.
A Stage by Stage Framework for Sponsor Recruitment Support Through Community Clinics
Effective sponsor recruitment support follows a structured sequence. The following framework outlines the five stages that sponsors and their partners should work through to build a community embedded enrollment program that performs from activation through study completion.
Stage 1: Protocol Feasibility and Community Site Mapping
Before a site list is finalized, sponsors should conduct a community site mapping exercise that identifies clinic networks with patient panels matching the protocol’s target population. This is not a standard feasibility survey. It involves querying electronic health record systems across community clinic networks to estimate the size of the pre qualified patient pool at each potential site, before a single screening visit occurs.
What to ask your sponsor recruitment support partner: How many community clinic sites in your network have treated patients matching our inclusion criteria in the past 24 months? What is the estimated pre screen eligible population per site?
Stage 2: Site Activation and Regulatory Infrastructure
Community clinics that have not previously participated in clinical research require regulatory infrastructure to be built or embedded before they can function as research sites. This includes IRB submission support, informed consent form development, FDA Form 1572 coordination, investigator training, and GCP certification. Sponsor recruitment support partners who have pre activated community site networks compress this timeline dramatically compared to activating a de novo site from scratch.
What to ask your sponsor recruitment support partner: Which sites in your network already have active IRB relationships and GCP certified investigators? What is your median time from contract execution to first patient screened at a community site?
Stage 3: Patient Identification and Pre Screening
With sites activated, the next stage of sponsor recruitment support is building the patient pipeline. EHR based pre screening allows community clinic networks to identify potentially eligible patients from existing records before any clinic visit occurs. This produces a pre qualified candidate pool that dramatically reduces screen failure rates and compresses the time between site activation and first patient enrolled.
What to ask your sponsor recruitment support partner: What EHR systems are you integrated with? How do you handle HIPAA compliance in the pre screening query process? What is your average screen failure rate across community clinic sites?
Stage 4: Multicultural Outreach and Patient Navigation
Pre screening identifies eligible patients. Outreach converts them into consented participants. For community clinic trials with diversity enrollment targets, outreach must go beyond digital advertising to include community health worker engagement, multilingual materials, and physician referral programs that activate the trust relationships community providers already have with their patients. Patient navigation services that assign a dedicated navigator to each enrolled participant from consent through last visit reduce dropout rates and protocol deviations that erode data quality.
What to ask your sponsor recruitment support partner: What languages are your outreach materials available in? Do you employ community health workers? What is your patient retention rate through study completion across community sites?
Stage 5: Sponsor Facing Reporting and Ongoing Optimization
Sponsor recruitment support does not end at enrollment. Real time reporting on site level metrics, including screen failure rates, enrollment velocity, dropout rates, and protocol deviation frequency, allows sponsors to identify underperforming sites early and reallocate resources before enrollment falls behind projections. Sponsors should expect dedicated dashboards, regular operational reviews, and proactive communication from their recruitment support partner on enrollment trajectory and risk.
What to ask your sponsor recruitment support partner: What does your sponsor facing dashboard look like? How frequently do you conduct operational reviews? What is your process for flagging a site that is falling behind its enrollment projection?
What Integrated Sponsor Recruitment Support Looks Like in Practice
The distinction between transactional sponsor recruitment support and integrated sponsor recruitment support is operational depth. A transactional model places sites, runs advertising, and reports enrollment numbers. An integrated model builds research infrastructure inside the community clinic, embeds the coordinator, manages the regulatory relationship, navigates the patient, and provides the sponsor with real time visibility into every stage of the enrollment pipeline.
FOMAT Medical operates as an Embedded Research Organization with a community clinic network designed specifically for integrated sponsor recruitment support. Rather than placing a trial at an existing site and hoping the clinic’s staff can absorb the research burden, FOMAT’s model embeds research infrastructure directly within the clinical setting. The research coordinator is part of the clinic’s operational environment. The regulatory relationship is maintained by the embedded team. The patient navigator is already known to the patients being approached for consent.
This model produces measurably different outcomes for sponsors. Screen to enroll conversion rates are higher because patients are approached by people they already know and trust. Protocol deviation rates are lower because the embedded coordinator is present at every visit. Dropout rates are lower because the patient navigator is actively managing barriers to continued participation. And sponsor visibility is higher because the embedded team is generating real time data at the site level rather than batch reporting at the end of each month.
FOMAT ERO and SMO Model
FOMAT Medical provides integrated sponsor recruitment support through an active community clinic network across the United States. Our embedded research model delivers site management, patient recruitment, coordinator support, regulatory infrastructure, and real time enrollment reporting for sponsors and CROs seeking community based trial access and diverse enrollment capability. Visit fomatmedical.com or contact our clinical operations team to discuss your trial’s enrollment needs.
How to Evaluate a Sponsor Recruitment Support Partner for Community Clinic Trials
Not every organization that describes itself as a sponsor recruitment support partner has the community infrastructure to deliver on that description. The following criteria separate partners with genuine community embedded capability from those offering a more traditional site network with community clinic terminology layered on top.
Existing Network Depth
Ask for specifics. How many community clinic sites are currently active in the partner’s network? How many have enrolled patients in the past 12 months? How many have active IRB relationships? A partner with genuine sponsor recruitment support capability will have concrete answers to these questions, not projections about sites they plan to recruit.
EHR Integration and Pre Screening Capability
The ability to query patient records compliantly before a screening visit is one of the clearest differentiators between a sponsor recruitment support partner with community infrastructure and one without it. Ask which EHR systems the partner is integrated with, how pre screening queries are structured for HIPAA compliance, and what the partner’s average pre screen eligible population estimate accuracy looks like relative to actual screen eligible patients at site activation.
Diversity Enrollment Track Record
Diversity enrollment goals are increasingly non negotiable for sponsors operating under FDA guidance and FDORA Act requirements. Ask prospective sponsor recruitment support partners for enrollment demographic data from recent trials. What percentage of enrolled patients identified as racial or ethnic minorities? What percentage were from rural or suburban geographies outside major metropolitan areas? What languages were used in patient facing materials?
Embedded Coordinator Model
Ask whether research coordinators are embedded within community clinic operations or managed centrally from a remote location. The difference matters. An embedded coordinator who is physically present in the clinic, known to the patients, and integrated into the clinic’s scheduling and documentation workflows produces meaningfully better protocol compliance, lower screen failure rates, and lower dropout rates than a centrally managed coordinator who visits the site periodically.
Sponsor Facing Reporting Infrastructure
Sponsor recruitment support is only valuable if the sponsor can see what is happening in real time. Ask to see a demo of the partner’s enrollment dashboard. What metrics are tracked at the site level? How frequently is data updated? What is the process for escalating a site that is underperforming relative to its enrollment projection? A partner with mature sponsor recruitment support infrastructure will have clear, specific answers to each of these questions.
Frequently Asked Questions: Sponsor Recruitment Support for Community Clinic Trials
What does sponsor recruitment support typically include?
Sponsor recruitment support covers the full operational range from site identification and activation through patient enrollment and retention. In community clinic settings, this includes EHR based pre screening, embedded research coordinator placement, multicultural outreach, patient navigation, IRB and regulatory support, and real time sponsor facing reporting. The scope varies by partner, but sponsors should expect a full service model to cover all of these functions rather than a narrow advertising or site placement service.
How early in the trial planning process should sponsors engage a recruitment support partner?
As early as possible, ideally at the protocol design stage. Sponsor recruitment support partners who are engaged during protocol development can provide feasibility input on inclusion and exclusion criteria that affect enrollment difficulty, recommend community site networks based on patient population availability, and begin the site activation and regulatory preparation process in parallel with IND submission. Sponsors who engage recruitment support partners after protocol finalization and site selection lose the ability to optimize the protocol for community clinic enrollment.
What is the difference between a sponsor recruitment support partner and a CRO?
A contract research organization manages the full operational scope of a clinical trial including protocol design, regulatory submissions, data management, biostatistics, and final reporting. A sponsor recruitment support partner focuses specifically on site activation, patient identification, enrollment, and retention. Some ERO and SMO organizations like FOMAT Medical provide both site management and recruitment support within an integrated model, reducing the coordination burden for sponsors who would otherwise manage multiple vendors across these functions.
How do community clinic based sponsor recruitment support models handle protocol deviations?
Community clinic sites with embedded coordinator support handle protocol deviations through the same corrective action processes required at any clinical trial site: deviation identification, root cause analysis, and corrective action plan development. The embedded coordinator model reduces deviation frequency by ensuring a trained research professional is present at every protocol required visit, reviewing source documentation in real time, and identifying potential deviations before they occur rather than after the fact.
What therapeutic areas are best suited to community clinic based sponsor recruitment support?
Community clinic networks are particularly well suited to therapeutic areas where the target patient population is prevalent in primary care settings: cardiovascular disease, type 2 diabetes, metabolic syndrome, hypertension, chronic kidney disease, respiratory conditions, and mental health indications. They are also effective for trials with diversity enrollment requirements across any therapeutic area, given the demographic composition of community clinic patient panels. Oncology trials are more variable and depend on the specific tumor type and treatment setting.
Building a Long Term Sponsor Recruitment Support Strategy
The sponsors who get the most value from community based sponsor recruitment support are those who treat it as a long term capability rather than a per trial vendor relationship. Building a durable relationship with an ERO or SMO that has community clinic infrastructure means that each successive trial benefits from a site network that is already activated, investigators who are already trained, coordinators who are already embedded, and patients who already have a positive association with clinical research participation.
The compounding effect of this model is significant. A sponsor who runs three consecutive trials through the same community embedded recruitment support partner does not start from zero on site activation for trial three. They start from a network that has already proven its enrollment capability, with regulatory files already current, with investigators who already know the sponsor’s data quality expectations, and with a patient population that has already experienced what clinical trial participation looks like in a community setting they trust.
That is what effective sponsor recruitment support looks like at scale. Not a campaign. Not a site list. A research infrastructure that lives inside the communities where patients actually live, operated by partners who have built it deliberately and maintained it continuously.
Partner With FOMAT for Sponsor Recruitment Support
FOMAT is an Embedded Research Organization providing integrated sponsor recruitment support through a community clinic network across the United States. Our model delivers site management, patient recruitment, embedded coordinator support, regulatory infrastructure, real time enrollment reporting, and diversity enrollment capability for pharmaceutical sponsors and CROs. To discuss your trial’s community based enrollment needs, visit fomatmedical.com or contact our clinical operations team directly.
Summary
Sponsor recruitment support that delivers consistent results requires more than advertising budgets and site lists. It requires community infrastructure: activated sites with embedded coordinators, EHR pre screening capability, multicultural outreach programs, patient navigation services, and real time sponsor facing reporting that gives clinical operations teams the visibility they need to manage enrollment actively rather than reactively.
Community clinics are not a fallback enrollment channel for sponsors who have exhausted their academic center options. They are a primary enrollment channel that has been structurally underutilized because the infrastructure to support them has historically been absent. Sponsors who build their sponsor recruitment support strategy around community embedded partners are not just solving a short term enrollment problem. They are building a clinical research capability that compounds in value with each successive trial.